Essec\Faculty\Model\Contribution {#2233
#_index: "academ_contributions"
#_id: "13245"
#_source: array:26 [
"id" => "13245"
"slug" => "abiraterone-acetate-versus-docetaxel-for-metastatic-castration-resistant-prostate-cancer-a-cohort-study-within-the-french-nationwide-claims-database"
"yearMonth" => "2022-08"
"year" => "2022"
"title" => "Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database"
"description" => "THURIN, N., ROUYER, M., JOVÉ, J., GROSS-GOUPIL, M., HAASER, T., REBILLARD, X. ... BLIN, P. (2022). Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database. <i>Expert Review of Clinical Pharmacology</i>, 15(9), pp. 1139-1145."
"authors" => array:16 [
0 => array:3 [
"name" => "PUYOU DE POUVOURVILLE Gérard"
"bid" => "B00072308"
"slug" => "de-pouvourville-gerard"
]
1 => array:1 [
"name" => "THURIN Nicolas"
]
2 => array:1 [
"name" => "ROUYER Magali"
]
3 => array:1 [
"name" => "JOVÉ Jérémy"
]
4 => array:1 [
"name" => "GROSS-GOUPIL Marine"
]
5 => array:1 [
"name" => "HAASER Thibaud"
]
6 => array:1 [
"name" => "REBILLARD Xavier"
]
7 => array:1 [
"name" => "SOULIÉ Michel"
]
8 => array:1 [
"name" => "CAPONE Camille"
]
9 => array:1 [
"name" => "BAZIL Marie-Laure"
]
10 => array:1 [
"name" => "MESSAOUD Fatiha"
]
11 => array:1 [
"name" => "LAMARQUE Stéphanie"
]
12 => array:1 [
"name" => "BIGNON Emmanuelle"
]
13 => array:1 [
"name" => "DROZ-PERROTEAU Cécile"
]
14 => array:1 [
"name" => "MOORE Nicholas"
]
15 => array:1 [
"name" => "BLIN Patrick"
]
]
"ouvrage" => ""
"keywords" => array:2 [
0 => "prostate cancer"
1 => "treatment"
]
"updatedAt" => "2023-08-25 09:23:51"
"publicationUrl" => "https://doi.org/10.1080/17512433.2022.2115356"
"publicationInfo" => array:3 [
"pages" => "1139-1145"
"volume" => "15"
"number" => "9"
]
"type" => array:2 [
"fr" => "Articles"
"en" => "Journal articles"
]
"support_type" => array:2 [
"fr" => "Revue scientifique"
"en" => "Scientific journal"
]
"countries" => array:2 [
"fr" => "Royaume-Uni"
"en" => "United Kingdom"
]
"abstract" => array:2 [
"fr" => """
The aim of the article is to conduct the direct comparison of abiraterone acetate and docetaxel for first-line treatment of metastatic castration-resistant prostate cancer (mCRPC) in real-life settings.\n
The findings underline the interest of oral abiraterone acetate over intravenous docetaxel as the first-line treatment option in mCRPC.
"""
"en" => """
The aim of the article is to conduct the direct comparison of abiraterone acetate and docetaxel for first-line treatment of metastatic castration-resistant prostate cancer (mCRPC) in real-life settings.\n
The findings underline the interest of oral abiraterone acetate over intravenous docetaxel as the first-line treatment option in mCRPC.
"""
]
"authors_fields" => array:2 [
"fr" => "Management"
"en" => "Management"
]
"indexedAt" => "2024-12-22T16:21:42.000Z"
"docTitle" => "Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database"
"docSurtitle" => "Articles"
"authorNames" => "<a href="/cv/de-pouvourville-gerard">PUYOU DE POUVOURVILLE Gérard</a>, THURIN Nicolas, ROUYER Magali, JOVÉ Jérémy, GROSS-GOUPIL Marine, HAASER Thibaud, REBILLARD Xavier, SOULIÉ Michel, CAPONE Camille, BAZIL Marie-Laure, MESSAOUD Fatiha, LAMARQUE Stéphanie, BIGNON Emmanuelle, DROZ-PERROTEAU Cécile, MOORE Nicholas, BLIN Patrick"
"docDescription" => "<span class="document-property-authors">PUYOU DE POUVOURVILLE Gérard, THURIN Nicolas, ROUYER Magali, JOVÉ Jérémy, GROSS-GOUPIL Marine, HAASER Thibaud, REBILLARD Xavier, SOULIÉ Michel, CAPONE Camille, BAZIL Marie-Laure, MESSAOUD Fatiha, LAMARQUE Stéphanie, BIGNON Emmanuelle, DROZ-PERROTEAU Cécile, MOORE Nicholas, BLIN Patrick</span><br><span class="document-property-authors_fields">Management</span> | <span class="document-property-year">2022</span>"
"keywordList" => "<a href="#">prostate cancer</a>, <a href="#">treatment</a>"
"docPreview" => "<b>Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database</b><br><span>2022-08 | Articles </span>"
"docType" => "research"
"publicationLink" => "<a href="https://doi.org/10.1080/17512433.2022.2115356" target="_blank">Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database</a>"
]
+lang: "fr"
+"_type": "_doc"
+"_score": 8.764241
+"parent": null
}